Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexinidazole for Visceral Leishmaniasis in Sudan
NCT01980199Phase 2Terminated
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Nov 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fexinidazole in visceral leishmaniasis (VL), sponsored by Drugs for Neglected Diseases initiative. Started Nov 2013; status: terminated.
02
Drugs
Fexinidazole
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT01980199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01980199.